A vaginal gel containing the HIV drug tenofovir has shown promise as a safe and effective method for reducing HIV infection in women, according to a study conducted in South Africa. The study was published Monday 19 July at the Science Express website.

HIV prevention options for women are urgently needed, especially in sub-Saharan Africa where young women bear the greatest burden of the HIV epidemic.